Biochemical markers of bone metabolism in breast cancer patients with bone metastases

Biochemical markers of bone metabolism in breast cancer patients with bone metastases

Osteoprotegerin as a prognostic marker in patients with breast cancer

The effect of Bisphosphonates on skeletal-relatedevents of metastatic bladder cancer : A controlled randomized study

RANKL as a prognostic marker in patients with breast cancer

Evaluation of different biochemical markers of bone turnover as a diagnostic tool for osteoporosis in postmenopausal women

Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a marker of bone metastasis from lung cancer

Osteoprotegerin and crosslaps, new markers of bone remodeling in postmenopausal osteoporosis

Assessment of clinical and biological effect of single fraction versus fractionated palliative radiotherapy of bone metastases

THE PROGNOSTIC AND PREDICTIVE VALUE OF SERUM BONE BIOMARKER (CTX) IN PATIENTS WITH BREAST CANCER METASTATIC TO BONE RECEIVING ZOLEDRONIC ACID